These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8094217)

  • 1. Interaction of lamotrigine with sodium valproate.
    Panayiotopoulos CP; Ferrie CD; Knott C; Robinson RO
    Lancet; 1993 Feb; 341(8842):445. PubMed ID: 8094217
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic interaction of lamotrigine and sodium valproate in intractable myoclonic epilepsy.
    Ferrie CD; Panayiotopoulos CP
    Seizure; 1994 Jun; 3(2):157-9. PubMed ID: 8081644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotoxicity following addition of intravenous valproate to lamotrigine therapy.
    Burneo JG; Limdi N; Kuzniecky RI; Knowlton RC; Mendez M; Lawn N; Faught E; Welty TE; Prasad A
    Neurology; 2003 Jun; 60(12):1991-2. PubMed ID: 12821749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of lamotrigine in the treatment of absence epilepsy crises].
    Mauri-Llerda JA; Tejero-Juste C; Iñiguez C; Morales-Asín F
    Rev Neurol; 2001 Feb 1-15; 32(3):247-50. PubMed ID: 11310280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early cyclosporine treatment of incipient toxic epidermal necrolysis induced by concomitant use of lamotrigine and sodium valproate.
    Hashim N; Bandara D; Tan E; Ilchyshyn A
    Acta Derm Venereol; 2004; 84(1):90-1. PubMed ID: 15040495
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of lamotrigine on valproic acid concentrations.
    Martin AC; Besag FM; Berry DJ; Besag FP
    Curr Drug Saf; 2011 Feb; 6(1):23-9. PubMed ID: 21241246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Posner EB; Mohamed K; Marson AG
    Cochrane Database Syst Rev; 2003; (3):CD003032. PubMed ID: 12917940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy.
    Sale ME; Natarajan S; Biton V; Vuong A; Hammer AE; Messenheimer JA; Blum D
    Epilepsy Behav; 2005 Feb; 6(1):63-70. PubMed ID: 15652736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamotrigine and absence seizures: new indication. Try valproic acid first.
    Prescrire Int; 2009 Dec; 18(104):249. PubMed ID: 20025089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of lamotrigine (LTG) monotherapy.
    Panayiotopoulos CP
    Epilepsia; 2000 Mar; 41(3):357-9. PubMed ID: 10714412
    [No Abstract]   [Full Text] [Related]  

  • 11. Valproate effects on kinetics of lamotrigine in pregnancy and treatment with oral contraceptives.
    Tomson T; Luef G; Sabers A; Pittschieler S; Ohman I
    Neurology; 2006 Oct; 67(7):1297-9. PubMed ID: 17030773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium valproate acutely inhibits lamotrigine metabolism.
    Yuen AW; Land G; Weatherley BC; Peck AW
    Br J Clin Pharmacol; 1992 May; 33(5):511-3. PubMed ID: 1524964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of treatment of typical absence seizures in children and adolescents with ethosuximide, sodium valproate or lamotrigine.
    Posner EB; Mohamed K; Marson AG
    Seizure; 2005 Mar; 14(2):117-22. PubMed ID: 15694565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
    Jozwiak S; Terczynski A
    Seizure; 2000 Oct; 9(7):486-92. PubMed ID: 11034873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.
    Glauser TA; Cnaan A; Shinnar S; Hirtz DG; Dlugos D; Masur D; Clark PO; Capparelli EV; Adamson PC;
    N Engl J Med; 2010 Mar; 362(9):790-9. PubMed ID: 20200383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effect of docosahexaenoic acid on anticonvulsant activity of valproic acid and lamotrigine in animal seizure models.
    Gavzan H; Sayyah M; Sardari S; Babapour V
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Oct; 388(10):1029-38. PubMed ID: 26018398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro.
    Schaub N; Bircher AJ
    Allergy; 2000 Feb; 55(2):191-3. PubMed ID: 10726736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bidirectional interaction of valproate and lamotrigine in healthy subjects.
    Anderson GD; Yau MK; Gidal BE; Harris SJ; Levy RH; Lai AA; Wolf KB; Wargin WA; Dren AT
    Clin Pharmacol Ther; 1996 Aug; 60(2):145-56. PubMed ID: 8823232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antiepileptic drug comedication on lamotrigine concentrations.
    Lovrić M; Čajić I; Petelin Gadže Ž; Klarica Domjanović I; Božina N
    Croat Med J; 2018 Feb; 59(1):13-19. PubMed ID: 29498493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lamotrigine (Lamictal)].
    Scheen AJ
    Rev Med Liege; 1997 Nov; 52(11):738-40. PubMed ID: 9480501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.